Your browser doesn't support javascript.
loading
The alteration of pharmacokinetics of erlotinib and OSI420 in type 1 diabetic rabbits.
Karbownik, Agnieszka; Szalek, Edyta; Sobanska, Katarzyna; Grabowski, Tomasz; Wolc, Anna; Grzeskowiak, Edmund.
Afiliação
  • Karbownik A; Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, Poznan, Poland.
  • Szalek E; Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, Poznan, Poland.
  • Sobanska K; Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, Poznan, Poland. Electronic address: sobanska.katarzyna@gmail.com.
  • Grabowski T; Polpharma Biologics, Gdansk, Poland.
  • Wolc A; Department of Animal Science, Iowa State University, Ames, USA; Hy-Line International, Dallas Center, USA.
  • Grzeskowiak E; Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, Poznan, Poland.
Pharmacol Rep ; 68(5): 964-8, 2016 Oct.
Article em En | MEDLINE | ID: mdl-27372922
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 1 / Cloridrato de Erlotinib Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 1 / Cloridrato de Erlotinib Idioma: En Ano de publicação: 2016 Tipo de documento: Article